DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
PRVA logo

Privia Health Group, Inc. Stock Price

NasdaqGS:PRVA Community·US$2.7b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 13 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

PRVA Share Price Performance

US$20.42
-2.26 (-9.96%)
​
US$31.42
Fair Value
US$20.42
-2.26 (-9.96%)
35.0% undervalued intrinsic discount
US$31.42
Fair Value
Price US$20.42
AnalystConsensusTarget US$31.42
Fri, 19 Jun 26
Fair ValueUS$31.42
Share Pricen/a

PRVA Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$31.42 35.0% undervalued intrinsic discount

Aging US Demographics And AI Adoption Will Transform Healthcare Services

1users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
PRVA logo
Privia Health Group
35.0% undervalued intrinsic discount

Aging US Demographics And AI Adoption Will Transform Healthcare Services

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 19 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
PRVA logo

PRVA: New Jersey Expansion And Durable Managed Care Trends Will Support Returns

Fair Value: US$31.42 35.0% undervalued intrinsic discount
7 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Flawless balance sheet with solid track record.

0 Risks
4 Rewards
View Full Analysis

Privia Health Group, Inc. Key Details

US$2.4b

Revenue

US$2.1b

Cost of Revenue

US$236.5m

Gross Profit

US$208.4m

Other Expenses

US$28.1m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.22
10.03%
1.19%
0%
View Full Analysis

About PRVA

Founded
2007
Employees
1226
CEO
Parth Mehrotra
WebsiteView website
www.priviahealth.com

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers’ workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.

Recent PRVA News & Updates

Recent updates

No updates

Privia Health Group, Inc. Competitors

SOLV logo

Solventum

Symbol: NYSE:SOLV
Market cap: US$15.3b
COO logo

Cooper Companies

Symbol: NasdaqGS:COO
Market cap: US$13.2b
BTSG logo

BrightSpring Health Services

Symbol: NasdaqGS:BTSG
Market cap: US$13.0b
BAX logo

Baxter International

Symbol: NYSE:BAX
Market cap: US$12.9b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide